Alexion Pharmaceuticals Logo

Alexion Pharmaceuticals

Professional, scientific and technical activities

About the company
Jobs0

Here, every employee has a stake in the lives of the patients we serve. We never shy away from daunting challenges, because we're fighting for patients who often have no other options-many of whom are infants and children. We push scientific boundaries, work outside of our comfort zones and stand up to adversity, because lives depend on our collective success. With this great responsibility comes the satisfaction that your contribution makes a real and significant difference.

There are limitless opportunities for talented individuals to work across functions and geographies, taking on new challenges and building the future of the company. 

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies.

Alexion was established in the U.S. in 1992 and became a public company in 1996 (NASDAQ: ALXN). We were added to the NASDAQ-100 Index in 2011 and to the Standard & Poor's 500 Index in 2012. Alexion’s global headquarters are currently in New Haven, Conn. In September 2017, the Company announced that it would relocate its headquarters to Boston, Mass., by mid-2018 and that New Haven would serve as the Company’s Center of Excellence for its world-class complement research and process development teams. Alexion's employees around the world serve patients in approximately 50 countries.

Up to 3000Employees
1992Year of foundation

Contact Information